Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 7, 2015, Pages 820-830

  Mandalakas, Anna M ^a,b,c   Kirchner, H Lester ^d   Walzl, Gerhard ^c   Gie, Robert P ^c   Schaaf, H Simon ^c   Cotton, Mark F ^c   Grewal, Harleen M S ^e,f   Hesseling, Anneke C ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d GEISINGER MEDICAL CENTER   (United States)

^e UNIVERSITY OF BERGEN   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

HIV; IFN release tests; Latent tuberculosis infection; Pediatrics; Tuberculin test

Indexed keywords

ARTICLE; BACTERIAL LOAD; BCG VACCINATION; BLACK PERSON; CHILD; CHILDHOOD DISEASE; CONTACT EXAMINATION; FEMALE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TASK PERFORMANCE; TUBERCULIN TEST; TUBERCULOSIS; VIRUS LOAD; ADOLESCENT; COMPLICATION; EARLY DIAGNOSIS; INFANT; LATENT TUBERCULOSIS; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PROCEDURES; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 84926651603     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1165OC     Document Type: Article

References (44)

1. Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med 2014;190:1044-1052.
2. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tubercul Lung Dis 2004;8:392-402.
3. Smieja M, Marchetti C, Cook D, Smaill F. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 1999;(1):CD001363.
4. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Databases Syst Rev 2004;(1):CD000171.
5. Hsu KH. Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children. JAMA 1974;229:528-533.
6. Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis 2014;14:91.
7. Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health 2014;2:e453-e459.
8. Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis 2012;205:S216-S227.
9. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis - United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:181-185.
10. Pareek M, Bond M, Shorey J, Seneviratne S, Guy M, White P, Lalvani A, Kon OM. Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis. Thorax 2012;68:230-239.
11. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: WHO; 2006.
12. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-1104.
13. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tubercul Lung Dis 2011;15:1018-1032.
14. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011;30:694-700.
15. Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis 2012;18:1422-1429.
16. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
17. National Collaborating Centre for Chronic Conditions, Centre for Clinical Practice at NICE. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence; 2011.
18. World Health Organization. Use of tuberculosis interferon-gamma release assays in low- and middle-income countries. Geneva: WHO; 2011.
19. Corrigal J. Western Cape Provincial EPI vaccination survey [serial online]. 2005 [cited 2009 September 29]. Available from: www.capegateway.gov.za/Text/2007/6/cd-volume-7-childhood-diseases-overview.pdf
20. Mandalakas A, Kirchner HL, Lombard C, Wazyl G, Gie R, Hesseling A. Well quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection in children. Int J Tubercul Lung Dis 2012;16:1033-1039.
21. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006;118:e1350-e1359.
22. Marais BJ, Gie RP, Schaaf HS, Starke JR, Hesseling AC, Donald PR, Beyers N. A proposed radiological classification of childhood intrathoracic tuberculosis. Pediatr Radiol 2004;34:886-894.
23. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-44.
24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
25. Diggle P, Liang K, Zeger S. Analysis of longitudinal data. New York: Oxford University Press; 1994.
26. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-1060.
27. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161(Suppl 3):S221-S247.
28. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007;175:618-627.
29. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-1173.
30. Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005;366:1443-1451.
31. Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, Stanley K, Zhu X, Black G, Beyers N, Walzl G. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 2009;64:840-846.
32. Tieu HV, Suntarattiwong P, Puthanakit T, Chotpitayasunondh T, Chokephaibulkit K, Sirivichayakul S, Buranapraditkun S, Rungrojrat P, Chomchey N, Tsiouris S, et al.; Thai TB Px Study Group. Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure. PLoS One 2014;9:e105003.
33. Basu Roy R, Sotgiu G, Altet-Gómez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am J Respir Crit Care Med 2012;186:378-384.
34. Jenum S, Selvam S, Mahelai D, Jesuraj N, Cardenas V, Kenneth J, Hesseling A, Doherty M, Vaz M, Grewal H. Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB Gold In-Tube in young children evaluated for tuberculosis in Southern India. Ped Infectious Dis J 2014;33:e260-e269.
35. Cruz AT, Geltemeyer AM, Starke JR, Flores JA, Graviss EA, Smith KC. Comparing the tuberculin skin test and T-SPOT.TB blood test in children. Pediatrics 2011;127:e31-e38.
36. Rose W, Read S, Bitnun A, Rea E, Stephens D, Pongsamart W, Kitai I. Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic. J Ped Infect Dis [online ahead of print] 8 Apr 2014; DOI: 10.1093/jpids/piu024.
37. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005;19:2109-2116.
38. Sutherland R, Yang H, Scriba TJ, Ondondo B, Robinson N, Conlon C, Suttill A, McShane H, Fidler S, McMichael A, et al. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. AIDS 2006;20:821-829.
39. Hsieh SM, Hung CC, Pan SC, Wang JT, Tsai HC, Chen MY, Chang SC. Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation. J Acquir Immune Defic Syndr 2000;25:212-220.
40. Mandalakas AM, van Wyk S, Kirchner HL, Walzl G, Cotton M, Rabie H, Kriel B, Gie RP, Schaaf HS, Hesseling AC. Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction. Pediatr Infect Dis J 2012;32:e111-e118.
41. Critselis E, Amanatidou V, Syridou G, Spyridis NP, Mavrikou M, Papadopoulos NG, Tsolia MN. The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. J Pediatr 2012;161:632-638.
42. Mukherjee A, Saini S, Kabra SK, Gupta N, Singh V, Singh S, Bhatnagar S, Saini D, Grewal HM, Lodha R; Delhi TB Study Group. Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis. Eur J Clin Nutr 2014;68:38-42.
43. Riazi S, Zeligs B, Yeager H, Peters SM, Benavides GA, Di Mita O, Bellanti JA. Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs). Allergy Asthma Proc 2012;33:217-226.
44. Mandalakas AM, Hesseling AC, Gie RP, Schaaf HS, Marais BJ, Sinanovic E. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2012;68:247-255.